Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06633666 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 13, 2024 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 2 to 1
    • Secondary endpoints: 3 to 6
    • Study description revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study, a 12-week pragmatic, randomized, double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment.
Trial Details
NCT Number NCT06633666
Lead Sponsor Hong Kong Baptist University
Conditions
(from sponsor)		 Long Covid19, Neuropsychiatric Symptom, Acupuncture
Related terms Post-Acute COVID-19 Syndrome
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov